Is the US prepared to deal with another pandemic or widespread health crisis?
No, the US is only partially prepared—better equipped in some areas than before COVID-19 due to stockpile rebuilds, surveillance upgrades, experience, and institutional changes, but significant gaps in sustained funding, workforce, coordination, and implementation of lessons learned leave it vulnerable to another major pandemic or widespread crisis.[1]
Improvements Since COVID-19
The Biden-Harris Administration and prior efforts addressed some glaring pre-2020 weaknesses:
COVID experience itself built operational knowledge, private-sector partnerships, and mRNA/platform technologies for faster countermeasures.
Persistent and Emerging Gaps
Multiple independent assessments highlight incomplete progress and risks of backsliding:
Bottom Line
The US has stronger stockpiles, better data systems in places, proven rapid MCM development potential, and hard-won experience compared to 2019. It can handle moderate outbreaks or known threats (as with mpox or contained H5N1) better than before. However, for a severe, novel, or highly transmissible pandemic—especially one straining hospitals, supply chains, and trust simultaneously—experts (GAO, Bipartisan Commission, public health leaders) assess it as inadequately prepared due to incomplete lesson implementation, fragile sustained funding/workforce, and coordination gaps.[10]
Preparedness is a continuous process requiring political will, stable multi-year funding for public health infrastructure (beyond emergency supplements), clearer authorities, resilient supply chains, and whole-of-society engagement. Without addressing these, the US risks repeating or worsening COVID-scale outcomes. Recent funding and staffing trends in 2025–2026 appear to reverse some post-COVID gains, heightening concerns. Ongoing monitoring of threats like H5N1, plus investments in platforms (mRNA, diagnostics), provide a foundation, but experts emphasize that “immediate action” and sustained commitment are still required.
Citations (10)
- https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “No, the US is only partially prepared—better equipped in some areas than before COVID-19 due to stockpile rebuilds, surveillance upgrades, experience, and institutional changes, but significant gaps in sustained funding, workforce, coordination, and implementation of lessons learned leave it vulnerable to another…”
- https://ghsindex.org/country/united-states/
Backs: “A 2024 Joint External Evaluation (JEE) under International Health Regulations and 2024 SPAR self-assessment showed relatively strong capacities (SPAR overall around 84%), though with recommendations for better alignment across federal/state/local levels and addressing gaps.”
- https://www.aspr.gov/readiness-response/responses/asprs-response-h5n1-bird-flu
Backs: “Human cases remained limited (dozens reported, mostly occupational, low general public risk as of mid-2025 updates), with emergency response later deactivated as activity declined.”
- https://www.gao.gov/products/gao-24-107175
Backs: “Boom-bust funding (surge during crises, cuts afterward) makes infrastructure and workforce gains temporary.”
- https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/
Backs: “Sustained “on all the time” investment is needed rather than reactive spending.”
- https://www.gao.gov/products/gao-24-105891
Backs: “Burnout, recruitment/retention issues, and state/local variations persist.”
- https://www.nejm.org/doi/full/10.1056/NEJMp2406427
Backs: “Hospital and broader system strains from concurrent threats (e.g., weather disasters as “threat multipliers”) are noted in national preparedness reports.”
- https://www.gao.gov/products/gao-23-105713
Backs: “Recent policy shifts (e.g., on certain research or vaccine contracts) and funding volatility raise questions about long-term readiness.”
- https://features.csis.org/US-bird-flu-response/
Backs: “While contained so far, experts noted lagging data transparency, incomplete farm surveillance/testing early on, coordination challenges, and limited vaccine doses relative to population needs. Some vaccine development funding faced cuts.”
- https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/
Backs: “However, for a severe, novel, or highly transmissible pandemic—especially one straining hospitals, supply chains, and trust simultaneously—experts (GAO, Bipartisan Commission, public health leaders) assess it as inadequately prepared due to incomplete lesson implementation, fragile sustained funding/workforce, and…”